• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过向儿童进行气雾剂给药实现成功治疗效果的途径:一篇叙述性综述。

A path to successful patient outcomes through aerosol drug delivery to children: a narrative review.

作者信息

Ari Arzu

机构信息

Department of Respiratory Care, Texas State University, Round Rock, TX, USA.

出版信息

Ann Transl Med. 2021 Apr;9(7):593. doi: 10.21037/atm-20-1682.

DOI:10.21037/atm-20-1682
PMID:33987291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8105845/
Abstract

Although using aerosolized medications is a mainstay of treatment in children with asthma and other respiratory diseases, there are many issues in terms of device and interface selection, delivery technique and dosing, as well as patient and parental education that have not changed for half a century. Also, due to many aerosol devices and interfaces available on the market and the broad range of patient characteristics and requirements, providing effective aerosol therapy to children becomes a challenge. While aerosol delivery devices are equally effective, if they are age-appropriate and used correctly, the majority of aerosol devices require multiple steps to be used efficiently. Unfortunately, many children with pulmonary diseases have problems with the correct delivery technique and do not gain therapeutic benefits from therapy that result in poor disease management and increased healthcare costs. Therefore, the purpose of this paper is to review the current knowledge on aerosol delivery devices used in children and guide clinicians on the optimum device- and interface-selection, delivery technique, and dosing in this patient population. Strategies on how to deliver aerosolized medications in crying and distressed children and how to educate parents on aerosol therapy and promote patient adherence to prescribed medications are also provided. Future directions of aerosol therapy in children should focus on these issues and implement policies and clinical practices that highlight the potential solutions to these problems.

摘要

尽管使用雾化药物是哮喘和其他呼吸道疾病患儿治疗的主要手段,但在设备和接口选择、给药技术和剂量以及患者和家长教育方面存在许多问题,这些问题半个世纪以来一直没有改变。此外,由于市场上有许多雾化设备和接口,以及患者特征和需求的广泛差异,为儿童提供有效的雾化治疗成为一项挑战。虽然雾化给药设备如果适合年龄且使用正确同样有效,但大多数雾化设备需要多个步骤才能有效使用。不幸的是,许多患有肺部疾病的儿童在正确的给药技术方面存在问题,无法从治疗中获得治疗益处,导致疾病管理不善和医疗成本增加。因此,本文的目的是回顾目前关于儿童使用的雾化给药设备的知识,并指导临床医生在这一患者群体中进行最佳的设备和接口选择、给药技术和剂量确定。还提供了如何在哭闹和痛苦的儿童中给药雾化药物以及如何教育家长进行雾化治疗并促进患者遵医嘱用药的策略。儿童雾化治疗的未来方向应关注这些问题,并实施突出这些问题潜在解决方案的政策和临床实践。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1333/8105845/3acac0bffe61/atm-09-07-593-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1333/8105845/46b7c79eb246/atm-09-07-593-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1333/8105845/4fe08e07200b/atm-09-07-593-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1333/8105845/4519260940f7/atm-09-07-593-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1333/8105845/3acac0bffe61/atm-09-07-593-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1333/8105845/46b7c79eb246/atm-09-07-593-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1333/8105845/4fe08e07200b/atm-09-07-593-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1333/8105845/4519260940f7/atm-09-07-593-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1333/8105845/3acac0bffe61/atm-09-07-593-f4.jpg

相似文献

1
A path to successful patient outcomes through aerosol drug delivery to children: a narrative review.通过向儿童进行气雾剂给药实现成功治疗效果的途径:一篇叙述性综述。
Ann Transl Med. 2021 Apr;9(7):593. doi: 10.21037/atm-20-1682.
2
[Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)].《稳定期慢性气道疾病吸入装置规范应用中国专家共识(2023年版)》
Zhonghua Jie He He Hu Xi Za Zhi. 2023 Nov 12;46(11):1055-1067. doi: 10.3760/cma.j.cn112147-20230411-00167.
3
Individualized aerosol medicine: Integrating device into the patient.个体化气溶胶药物治疗:将装置整合入患者体内。
Paediatr Respir Rev. 2024 Mar;49:14-23. doi: 10.1016/j.prrv.2023.07.003. Epub 2023 Jul 17.
4
Special problems in aerosol delivery: neonatal and pediatric considerations.气雾剂给药的特殊问题:新生儿和儿科方面的考虑因素
Respir Care. 2000 Jun;45(6):646-51.
5
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
6
Patient Education and Adherence to Aerosol Therapy.患者教育与雾化治疗依从性
Respir Care. 2015 Jun;60(6):941-55; discussion 955-7. doi: 10.4187/respcare.03854.
7
Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology.雾化治疗的设备选择与疗效:循证指南:美国胸科医师学会/美国哮喘、过敏与免疫学会
Chest. 2005 Jan;127(1):335-71. doi: 10.1378/chest.127.1.335.
8
Aerosol therapy in children: challenges and solutions.儿童气溶胶治疗:挑战与解决方案。
Expert Rev Respir Med. 2013 Dec;7(6):665-72. doi: 10.1586/17476348.2013.847369.
9
Recent advances in aerosol devices for the delivery of inhaled medications.吸入药物气溶胶装置的最新进展。
Expert Opin Drug Deliv. 2020 Feb;17(2):133-144. doi: 10.1080/17425247.2020.1712356. Epub 2020 Jan 20.
10
Aerosol delivery devices in the treatment of asthma.用于治疗哮喘的气雾剂输送装置。
Respir Care. 2008 Jun;53(6):699-723; discussion 723-5.

引用本文的文献

1
Recent Developments in Aerosol Pulmonary Drug Delivery: New Technologies, New Cargos, and New Targets.气溶胶肺部药物传递的新进展:新技术、新载体和新靶标。
Annu Rev Biomed Eng. 2024 Jul;26(1):307-330. doi: 10.1146/annurev-bioeng-110122-010848. Epub 2024 Jun 20.
2
From the infant to the geriatric patient-Strategies for inhalation therapy in asthma and chronic obstructive pulmonary disease.从婴儿到老年患者——哮喘和慢性阻塞性肺疾病吸入治疗策略。
Clin Respir J. 2023 Jun;17(6):487-498. doi: 10.1111/crj.13610. Epub 2023 Apr 13.
3
Pharmacological Strategies and Recent Advancement in Nano-Drug Delivery for Targeting Asthma.

本文引用的文献

1
Quantifying continuous nebulization via high flow nasal cannula and large volume nebulizer in a pediatric model.通过儿童模型量化高流量鼻导管和大容积雾化器的持续雾化。
Pediatr Pulmonol. 2020 Oct;55(10):2596-2602. doi: 10.1002/ppul.24967. Epub 2020 Jul 24.
2
Recent advances in aerosol devices for the delivery of inhaled medications.吸入药物气溶胶装置的最新进展。
Expert Opin Drug Deliv. 2020 Feb;17(2):133-144. doi: 10.1080/17425247.2020.1712356. Epub 2020 Jan 20.
3
In vitro evaluation of aerosol drug delivery with and without high flow nasal cannula in children.
用于靶向治疗哮喘的纳米药物递送的药理学策略及最新进展
Life (Basel). 2022 Apr 18;12(4):596. doi: 10.3390/life12040596.
4
Reconciling Oxygen and Aerosol Delivery with a Hood on In Vitro Infant and Paediatric Models.在体外婴儿和儿科模型上使用头罩协调氧气和气溶胶输送
Pharmaceutics. 2021 Dec 31;14(1):91. doi: 10.3390/pharmaceutics14010091.
5
Quantifying Delivered Dose with Jet and Mesh Nebulizers during Spontaneous Breathing, Noninvasive Ventilation, and Mechanical Ventilation in a Simulated Pediatric Lung Model with Exhaled Humidity.在具有呼出湿度的模拟小儿肺模型中,对自发呼吸、无创通气和机械通气期间喷射雾化器和网式雾化器输送的剂量进行量化。
Pharmaceutics. 2021 Jul 30;13(8):1179. doi: 10.3390/pharmaceutics13081179.
儿童经鼻高流量湿化氧疗与常规吸氧下吸入药物的体外输送评估。
Pediatr Pulmonol. 2019 Dec;54(12):1968-1973. doi: 10.1002/ppul.24501. Epub 2019 Aug 29.
4
Effect of nebulizer type, delivery interface, and flow rate on aerosol drug delivery to spontaneously breathing pediatric and infant lung models.雾化器类型、输送接口和流速对自主呼吸儿科和婴儿肺模型中气溶胶药物输送的影响。
Pediatr Pulmonol. 2019 Nov;54(11):1735-1741. doi: 10.1002/ppul.24449. Epub 2019 Jul 16.
5
The Ratio of Nasal Cannula Gas Flow to Patient Inspiratory Flow on Trans-nasal Pulmonary Aerosol Delivery for Adults: An in Vitro Study.成人经鼻肺部气溶胶递送时鼻导管气体流量与患者吸气流量的比值:一项体外研究
Pharmaceutics. 2019 May 10;11(5):225. doi: 10.3390/pharmaceutics11050225.
6
Decrease the flow setting to improve trans-nasal pulmonary aerosol delivery via "high-flow nasal cannula" to infants and toddlers.降低流量设置可改善通过“高流量鼻导管”向婴儿和幼儿输送经鼻肺气溶胶。
Pediatr Pulmonol. 2019 Jun;54(6):914-921. doi: 10.1002/ppul.24274. Epub 2019 Mar 28.
7
Bronchodilator responsiveness in children with asthma is not influenced by spacer device selection.哮喘患儿支气管扩张剂反应性不受储雾罐装置选择的影响。
Pediatr Pulmonol. 2019 May;54(5):531-536. doi: 10.1002/ppul.24263. Epub 2019 Feb 4.
8
Nasal high-flow bronchodilator nebulization: a randomized cross-over study.经鼻高流量支气管扩张剂雾化:一项随机交叉研究。
Ann Intensive Care. 2018 Dec 20;8(1):128. doi: 10.1186/s13613-018-0473-8.
9
The Role of Inhalation Delivery Devices in COPD: Perspectives of Patients and Health Care Providers.吸入给药装置在慢性阻塞性肺疾病中的作用:患者与医护人员的观点
Chronic Obstr Pulm Dis. 2018 Apr 1;5(2):111-123. doi: 10.15326/jcopdf.5.2.2017.0168.
10
Mesh nebulizers have become the first choice for new nebulized pharmaceutical drug developments.网状雾化器已成为新型雾化药物研发的首选。
Ther Deliv. 2018 Feb;9(2):121-136. doi: 10.4155/tde-2017-0102.